Carlos Alberto Montanari (Carlos A Montanari)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 20

Top Venues

ChemMedChem

Journal of chemical information and modeling

RSC medicinal chemistry

PLoS neglected tropical diseases

Universidade de São Paulo Instituto de Química de São Carlos

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de São Paulo Instituto de Química de São Carlos Jul 23 2018

Brazil

Professor Titular :: Química

Universidade Federal de Minas Gerais

Brazil

Professor Adjunto :: Química

Publications

Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Vinícius Bonatto, Rafael F Lameiro, Fernanda R Rocho, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
Nitriles: an attractive approach to the development of covalent inhibitors. RSC medicinal chemistry 14 (2) (2022)
Fernanda R Rocho, Vinícius Bonatto, Rafael da Fonseca Lameiro, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
A patent review on cathepsin K inhibitors to treat osteoporosis (2011 - 2021). Expert opinion on therapeutic patents 32 (5) (2022)
Alberto M Dos Santos, Amanda Ruslana Santana Oliveira, Clauber H S da Costa, Peter W Kenny, Carlos Alberto Montanari, Jaldyr de Jesus G Varela, Jeronimo Lameira
Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces. Journal of chemical information and modeling 62 (17) (2022)
Vinícius Bonatto, Rafael F Lameiro, Fernanda R Rocho, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
Nitriles: an attractive approach to the development of covalent inhibitors. RSC medicinal chemistry 14 (2) (2022)
Vinícius Bonatto, Anwar Shamim, Fernanda Dos R Rocho, Andrei Leitão, Francisco Javier Luque, Jeronimo Lameira, Carlos Alberto Montanari
Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations. Journal of chemical information and modeling 61 (9) (2021)
Sérgio de Albuquerque, Lorenzo Cianni, Daniela de Vita, Carla Duque, Ana S M Gomes, Paula Gomes, Charles Laughton, Andrei Leitão, Carlos Alberto Montanari, Raphael Montanari, Jean F R Ribeiro, João Santana da Silva, Cátia Teixeira
Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment. Chemical biology & drug design 96 (3) (2021)
José Rogério A Silva, Lorenzo Cianni, Deborah Araujo, Pedro Henrique Jatai Batista, Daniela de Vita, Fabiana Rosini, Andrei Leitão, Jeronimo Lameira, Carlos Alberto Montanari
Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism. Journal of chemical information and modeling 60 (3) (2020)
Lorenzo Cianni, Carina Lemke, Erik Gilberg, Christian Feldmann, Fabiana Rosini, Fernanda Dos Reis Rocho, Jean F R Ribeiro, Daiane Y Tezuka, Carla D Lopes, Sérgio de Albuquerque, Jürgen Bajorath, Stefan Laufer, Andrei Leitão, Michael Gütschow, Carlos Alberto Montanari
Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. PLoS neglected tropical diseases 14 (3) (2020)
Rafael da Fonseca Lameiro, Anwar Shamim, Fabiana Rosini, Rodrigo Cendron, Pedro Henrique Jatai Batista, Carlos Alberto Montanari
Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds. Future medicinal chemistry 13 (1) (2020)
Clauber H S da Costa, Vinícius Bonatto, Alberto M Dos Santos, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors. Journal of chemical information and modeling 60 (2) (2020)
Vinicius Bonatto, Pedro Henrique Jatai Batista, Lorenzo Cianni, Daniela De Vita, Daniel G Silva, Rodrigo Cedron, Daiane Y Tezuka, Sérgio de Albuquerque, Carolina Borsoi Moraes, Caio Haddad Franco, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors. RSC medicinal chemistry 11 (11) (2020)
Carla Duque Lopes, Bruna Possato, Ana Paula S Gaspari, Ronaldo Junio de Oliveira, Ulrich Abram, José P A Almeida, Fernanda Dos Reis Rocho, Andrei Leitão, Carlos Alberto Montanari, Pedro I S Maia, João S da Silva, Sérgio de Albuquerque, Zumira A Carneiro
Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease. ACS infectious diseases 5 (10) (2019)
Lorenzo Cianni, Christian Wolfgang Feldmann, Erik Gilberg, Michael Gütschow, Luiz Juliano, Andrei Leitão, Jürgen Bajorath, Carlos Alberto Montanari
Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? Journal of medicinal chemistry 62 (23) (2019)
Antonio C B Burtoloso, Sérgio de Albuquerque, Mark Furber, Juliana C Gomes, Cristiana Gonçalez, Peter W Kenny, Andrei Leitão, Carlos Alberto Montanari, José Carlos Quilles, Jean F R Ribeiro, Josmar R Rocha
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors. PLoS neglected tropical diseases 11 (2) (2017)
Daniel Gedder Silva, Josmar Rodrigues Rocha, Geraldo Rodrigues Sartori, Carlos Alberto Montanari
Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors. Journal of biomolecular structure & dynamics 35 (15) (2016)

Carlos Alberto Montanari.css-eqlu8i{font-size:small;padding-left:4px;} (Carlos A Montanari)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Alberto Montanari (Carlos A Montanari)